The “Not Parent Expected” population uses the language of grief, trauma and loss: “blown up,” “robbed,” “dislocated.” ...

A husband is worried about his stay-at-home wife’s mental health after noticing pests around the house and dishes piling up.

Having ADHD is associated with a shorter life expectancy and a greater risk of mental health issues, according to a new study ...

This regulatory gap gives rise to critical questions pertaining to confidentiality ... ethical guidelines tailored specifically to psychiatric practice. Furthermore, enforcement of such guidelines ...

CBSE Class 10 Additional Practice Questions 2025: The Central Board of Secondary Education (CBSE) is the national-level education board of India. This educational board is well known for its up-to ...

Mental health issues vary hugely from person to person so what works for someone else ... If you'd prefer to speak to a member of staff and you’re not sure who to contact, the Enquiry Centre can often ...

Jim van Os, a psychiatrist and professor at the University Medical Center Utrecht, questions whether teens whose ... banning euthanasia on psychiatric grounds for patients younger than 25 or 30. But ...

The Family Psychiatric/Mental Health Nurse Practitioner (FPMHNP) program is to prepare the nurse interested in an advanced practice role in the health care system. The student receives preparation in ...

In late 2022, Erin, a 43-year-old from Pennsylvania, agreed to spend six weeks in a psychiatric ward ... Because there often aren’t conclusive tests for these types of complex chronic conditions ...

The Oregon Medical Board dropped the intrusive mental health questions on its medical licensure application in 2023 ... that currently affect your ability to practice, with or without reasonable ...

But amid their countless capabilities lies a dilemma: What can an ED do for more nebulous mental health issues ... many hours and be sent for various tests and scans, only to be assured that ...

Johnson & Johnson on Monday said it has agreed to acquire Intra-Cellular Therapies, a developer of drugs for diseases of the brain, for $132 per share, or about $14.6 billion. The announcement of the ...